Your browser doesn't support javascript.
loading
Involvement of the AKT Pathway in Resistance to Erlotinib and Cabozantinib in Triple-Negative Breast Cancer Cell Lines.
Lefebvre, Cory; Pellizzari, Sierra; Bhat, Vasudeva; Jurcic, Kristina; Litchfield, David W; Allan, Alison L.
Affiliation
  • Lefebvre C; London Regional Cancer Program, London Health Sciences Centre, London, ON N6A 5W9, Canada.
  • Pellizzari S; Department of Anatomy & Cell Biology, Western University, London, ON N6A 3K7, Canada.
  • Bhat V; London Regional Cancer Program, London Health Sciences Centre, London, ON N6A 5W9, Canada.
  • Jurcic K; Department of Anatomy & Cell Biology, Western University, London, ON N6A 3K7, Canada.
  • Litchfield DW; London Regional Cancer Program, London Health Sciences Centre, London, ON N6A 5W9, Canada.
  • Allan AL; Department of Anatomy & Cell Biology, Western University, London, ON N6A 3K7, Canada.
Biomedicines ; 11(9)2023 Aug 28.
Article in En | MEDLINE | ID: mdl-37760847
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Prognostic_studies Language: En Journal: Biomedicines Year: 2023 Document type: Article Affiliation country: Canada
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Prognostic_studies Language: En Journal: Biomedicines Year: 2023 Document type: Article Affiliation country: Canada